Highlights and Quick Summary
- Income after Tax for the quarter ending March 31, 2022 was $-31.5 Million (a 360.99% increase compared to previous quarter)
- Year-over-year quarterly Income after Tax increased by 317.89%
- Annual Income after Tax for 2021 was $40.1 Million (a -369.26% decrease from previous year)
- Annual Income after Tax for 2020 was $-14.9 Million (a 80.51% increase from previous year)
- Annual Income after Tax for 2019 was $-8.24 Million (a -21.4% decrease from previous year)
- Twelve month Income after Tax ending March 31, 2022 was $-51.8 Million (a 96.73% increase compared to previous quarter)
- Twelve month trailing Income after Tax increased by 75.9% year-over-year
Trailing Income after Tax for the last four month:
| 31 Mar '22 | 30 Sep '21 | 31 Mar '21 | 30 Sep '20 |
|---|---|---|---|
| $-51.8 Million | $-26.3 Million | $-32.3 Million | $-29.4 Million |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income after Tax of Biofrontera AG Sponsored ADR
Most recent Income after Taxof BFAGY including historical data for past 10 years.Interactive Chart of Income after Tax of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Income after Tax for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | $-31.53 | – |
| 2021 | – | – | $-6.84 | $-5.88 | $40.06 |
| 2020 | – | – | $-7.55 | $-6.06 | $-14.88 |
| 2019 | – | – | $-12.84 | $-3.0 | $-8.24 |
| 2018 | – | – | – | $-5.31 | $-10.48 |
| 2017 | – | – | $-6.91 | $-3.74 | $-18.2 |
| 2016 | $3.51 | – | – | – | $-11.71 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic